Nuveen
LUNG icon

Nuveen’s Pulmonx LUNG Stock Holding History

Nuveen’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.21K Buy
+4,669
New +$8.8K ﹤0.01% 4635
2026
Q2 		– Sell
-69,108
Closed -$89.2K – 3808
2026
Q1 		$89.2K Buy
69,108
+318
+0.5% +$525 ﹤0.01% 3182
2025
Q4 		$152K Hold
68,790
– – ﹤0.01% 3186
2025
Q3 		$111K Hold
68,790
– – ﹤0.01% 3217
2025
Q2 		$178K Sell
68,790
-129,733
-65% -$512K ﹤0.01% 3179
2025
Q1 		$1.34M Buy
198,523
+19,305
+11% +$137K ﹤0.01% 2508
2024
Q4 		$1.22M Hold
179,218
– – ﹤0.01% 2626
2024
Q3 		$1.49M Buy
179,218
+96,570
+117% +$699K ﹤0.01% 2572
2024
Q2 		$524K Sell
82,648
-72,016
-47% -$554K ﹤0.01% 2974
2024
Q1 		$1.43M Sell
154,664
-55,809
-27% -$654K ﹤0.01% 2550
2023
Q4 		$2.68M Sell
210,473
-42,970
-17% -$448K ﹤0.01% 2279
2023
Q3 		$2.62M Sell
253,443
-506
-0.2% -$5.86K ﹤0.01% 2184
2023
Q2 		$3.33M Buy
253,949
+17,619
+7% +$216K ﹤0.01% 2110
2023
Q1 		$2.64M Buy
236,330
+71,670
+44% +$708K ﹤0.01% 2224
2022
Q4 		$1.39M Buy
164,660
+77,184
+88% +$734K ﹤0.01% 2540
2022
Q3 		$1.46M Buy
87,476
+240
+0.3% +$4.42K ﹤0.01% 2563
2022
Q2 		$1.28M Sell
87,236
-13,019
-13% -$268K ﹤0.01% 2678
2022
Q1 		$2.38M Sell
100,255
-14,980
-13% -$387K ﹤0.01% 2423
2021
Q4 		$3.7M Buy
115,235
+10,453
+10% +$382K ﹤0.01% 2275
2021
Q3 		$3.77M Sell
104,782
-804
-0.8% -$31.6K ﹤0.01% 2362
2021
Q2 		$4.66M Buy
105,586
+43,661
+71% +$1.9M ﹤0.01% 2291
2021
Q1 		$2.83M Buy
61,925
+3,582
+6% +$205K ﹤0.01% 2448
2020
Q4 		$4.03M Buy
+58,343
New +$2.86M ﹤0.01% 2180

Other funds holding LUNG

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
CFM Wealth Partners
CFM Wealth Partners Austin, Texas $803M AUM 41.47% 1-Year Est. Return
Redhawk Wealth Advisors
Redhawk Wealth Advisors Minneapolis, Minnesota $987M AUM 25.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Brighton Jones LLC
Brighton Jones LLC Seattle, Washington $5.73B AUM 24.99% 1-Year Est. Return

Nuveen's LUNG Position: Q3 2026 in Review

Nuveen opened a new position in Pulmonx (LUNG) in Q3 2026: 4,669 shares worth $6.21K. The stake represents ﹤0.01% of the portfolio and ranks #4635 among its holdings. This is a return to the name: Nuveen previously reported a position in LUNG as recently as Q1 2026.

Nuveen first reported a position in LUNG in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.66M in Q2 2021. 34 funds tracked by Wall St. Rank hold LUNG as of Q3 2026.

  • Nuveen held 4,669 shares of Pulmonx worth $6.21K as of Q3 2026.
  • Pulmonx was a new Nuveen position in Q3 2026.
  • Pulmonx made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4635 holding.
  • Nuveen first reported a position in Pulmonx in Q4 2020 and has held it in 23 quarters since.
  • Nuveen's Pulmonx position peaked at $4.66M in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Pulmonx as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.